Evidence map›Paper›PMID 30378296›Full record

ArticleJournal of cachexia, sarcopenia and muscle2019

Experimental ischaemic stroke induces transient cardiac atrophy and dysfunction.

Roland Veltkamp, Stefan Uhlmann, Marilena Marinescu, Carsten Sticht, Daniel Finke, Norbert Gretz, Herrmann-Josef Gröne, Hugo A Katus, Johannes Backs, Lorenz H Lehmann

Open access · goldAbstract read
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Role of beta-blocker therapy on the sympathetic effects in stroke heart syndrome.Clinical autonomic research : official journal of the Clinical Autonomic Research Society · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Stroke-Heart Syndrome: Recent Advances and Challenges.Journal of the American Heart Association · 2022
    Review
  16. Observational
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Roland VeltkampDivision of Brain Sciences, Imperial College London, London, UK.
Stefan UhlmannDepartment of Neurology, University Heidelberg, Heidelberg, Germany.
Marilena MarinescuDivision of Brain Sciences, Imperial College London, London, UK.
Carsten StichtMedical Research Center, Medical Faculty Mannheim, Mannheim, Germany.
Daniel FinkeDepartment of Cardiology, University of Heidelberg, Heidelberg, Germany.
Norbert GretzMedical Research Center, Medical Faculty Mannheim, Mannheim, Germany.
Herrmann-Josef GröneDepartment of Cellular and Molecular Pathology, German Cancer Research Center, Heidelberg, Germany.
Hugo A KatusDepartment of Cardiology, University of Heidelberg, Heidelberg, Germany.
Johannes BacksDepartment of Molecular Cardiology and Epigenetics, University of Heidelberg, Heidelberg, Germany.
Lorenz H LehmannDepartment of Cardiology, University of Heidelberg, Heidelberg, Germany.
Heidelberg University · DEGerman Centre for Cardiovascular Research · DEUniversity Hospital Heidelberg · DEHeidelberg University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStroke can lead to cardiac dysfunction in patients, but the mechanisms underlying the interaction between the injured brain and the heart are poorly understood. The objective of the study is to investigate the effects of experimental murine stroke on cardiac function and molecular signalling in the heart. METHODS AND

resultsMice were subjected to filament-induced left middle cerebral artery occlusion for 30 or 60 min or sham surgery and underwent repetitive micro-echocardiography. Left ventricular contractility was reduced early (24-72 h) but not late (2 months) after brain ischaemia. Cardiac dysfunction was accompanied by a release of high-sensitive cardiac troponin (hsTNT (ng/ml): d1: 7.0 ± 1.0 vs. 25.0 ± 3.2*; d3: 7.3 ± 1.1 vs. 52.2 ± 16.7*; d14: 5.7 ± 0.8 vs. 5.2 ± 0.3; sham vs. 60 min. MCAO; mean ± SEM; *p < 0.05); reduced heart weight (heart weight/tibia length ratio: d1: 6.9 ± 0.2 vs. 6.4 ± 0.1*; d3: 6.7 ± 0.2 vs. 5.8 ± 0.1*; d14: 6.7 ± 0.2 vs. 6.4 ± 03; sham vs. 60 min. MCAO; mean ± SEM; *p < 0.05); resulting from cardiomyocyte atrophy (cardiomyocyte size: d1: 12.8% ± 0.002**; d3: 13.5% ± 0.002**; 14d: 6.3% ± 0.003*; 60 min. MCAO vs. sham; mean ± SEM; **p < 0.01; *p < 0.05), accompanied by increased atrogin-1 and the E3 ubiquitin ligase murf-1. Net norepinephrine but not synthesis was increased, suggesting a reduced norepinephrine release or an increase of norepinephrine re-uptake, resulting in a functional denervation. Transcriptome analysis in cardiac tissue identified the transcription factor peroxisome proliferator-activated receptor gamma as a potential mediator of stroke-induced transcriptional dysregulation involved in cardiac atrophy.

conclusionsStroke induces a complex molecular response in the heart muscle with immediate but transient cardiac atrophy and dysfunction.

Indexed as

AnimalsAtrophyHeartInfarction, Middle Cerebral ArteryMaleMice, Inbred C57BLMyocardiumStrokeAtrophyCardiac dysfunctionCardiomyocytesIschaemic strokeLeft ventricular contractility

Identifiers

PMID30378296
PMCPMC6438414
OpenAlexW2898705623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.